The University of Leeds is investigating the surgical treatment of Sacral nerve stimulation versus the FENIX magnetic sphincter augmentation for adult faecal incontinence: a Randomised Investigation (SaFaRI)
What is the purpose of this study?
The purpose of the SaFaRI study is to look at two different surgical treatments for those suffering from Faecal Incontinence (FI): surgery to implant the FENIXTM Magnetic Sphincter Augmentation (MSA), which is a string of magnetic beads implanted around the muscle that controls the bowel (anal sphincter), and surgery for Sacral Nerve Stimulation (SNS), which involves implanting an electrode and battery to stimulate the nerves that control bowel continence. Surgery for SNS implants is the current preferred treatment for FI and is approved by the National Institute for Health and Clinical Excellence (NICE).
Who is the study looking at?
The study is looking at people who suffer from moderate to severe FI symptoms (2 or more incontinent episodes per week) for more than 6 months and whose condition has not improved with other treatments.
Where is the study running?
The study is running at:
- Royal Devon & Exeter Hospital
- Northern General Hospital, Sheffield
- Royal Victoria Infirmary, Newcastle
- Southampton General Hospital
- St Peter’s Hospital, Chertsey
- Good Hope Hospital, Birmingham
- Dewsbury District Hospital
- Churchill Hospital, Oxford
What should I do if I am interested in participating?
If you are interested in participating, please print off this page SaFaRI Trial Letter and take to your next GP appointment